bpc 157 tb 500 legal status 𧬠Big news in the peptide world. , The FDA has scheduled a formal hearing in July to review 7 peptides β including BPC-157 and TB-500 β for compounding. , This isnβt approval. But itβs BPC-157/TB-500 Injectable | Starts at
Description
After 28 days, the peptide may still contain active tirzepatide, but the concentration could have dropped below the labeled amount, and bacterial contamination risk increases

I think it can be used in conjunction but should not be sold as a quick fix for things like patella tendinopathies, meniscus tears etc

What is the maximum temperature tirzepatide can tolerate

The two names describe the same research peptide, supplied for laboratory use only
